Tau proteins play an essential role in the normal functioning of the nervous system. They interact with tubulin, a spherical protein that serves as the building block of microtubules, which are critical components of a cell’s internal structure.
Under normal conditions, tau proteins bind to tubulin and help stabilize microtubules within the axon. The axon is the long extension of a neuron that carries electrical signals from one nerve cell to another. These microtubules function much like highways, allowing signals and essential materials to travel efficiently along the axon.
In certain neurodegenerative diseases, including Alzheimer’s disease, tau proteins become abnormal. Conditions characterized by tau dysfunction are known as tauopathies. In these disorders, tau proteins lose their ability to properly stabilize microtubules, leading to structural instability within neurons. This disruption interferes with communication in the central nervous system and contributes to symptoms such as memory loss and dementia.
Tau proteins are found primarily in neurons of the central nervous system. Several different forms, or isoforms, of tau exist, all of which are important for maintaining healthy nerve cell structure and function. Tau proteins were first identified in the 1970s, and research into their role in both healthy aging and neurodegenerative disease continues worldwide.
Grape Seed Polyphenols and Tau Protection
Research has suggested that polyphenols derived from grape seed may help protect tau proteins from pathological changes. In an in vitro study published in the Journal of Alzheimer’s Disease (2009;16(2):433–439), researchers found that grape seed polyphenolic extract (GPSE) inhibited the abnormal aggregation of tau proteins.
Additional laboratory evidence published in the Journal of Biological Chemistry (November 21, 2008; 283(47):32176–32187) supported these findings, showing that grape seed polyphenols interfered with molecular processes involved in tau disruption.
Animal research has produced similar results. In a mouse study published in the Journal of Neuroscience (June 18, 2008; 28(25):6388–6392), GPSE was shown to reduce tau-related pathology. The researchers also observed protection against cognitive decline and reductions in Alzheimer’s-like brain changes, including cerebral amyloid deposition.
These findings suggest that grape seed polyphenols may influence pathways involved in tau dysfunction and neurodegeneration. The results were based on laboratory and animal models and were presented as supportive evidence rather than proof of clinical benefit in humans.
